Both in Diagnostics
Intellia Therapeutics vs Lantheus Holdings
Over the past year NTLA returned −5.0% and LNTH returned +77.9%; their daily moves had a correlation of 0.22.
NTLA −5.0% LNTH +77.9%Growth of $1, one year, split-adjusted
| Metric | NTLA | LNTH |
|---|---|---|
| Price | $12.42 | $101.09 |
| Market cap | $1.74B | $6.60B |
| Today | +4.68% | +0.29% |
| 1 month | +0.4% | +1.1% |
| 6 months | −10.4% | +17.3% |
| Year to date | +38.1% | +51.9% |
| 1 year | −5.0% | +77.9% |
| Revenue growth (YoY) | −46.2% | +2.7% |
| Gross margin | 100.0% | 62.3% |
| Net margin | −1392.3% | 19.3% |
| P/E (TTM) | — | 24.0× |
| Price / sales | 29.2× | 4.2× |
| Net cash | $437.8M | $22.2M |
| Dividend yield | — | — |
| Volatility (60d) | 63.3% | 4.1% |
| Short % of float | 38.6% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).